ArticleJournal of Korean medical science2026
Economic Burden of Developmental Disorder Treatment in Korea and Various Overseas Policies: A Study on the Reinforcement for National Assistance.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundDevelopmental disorders are characterized by delays in motor skills, language, cognition, emotional regulation, and social abilities. The most common conditions within this category include intellectual disabilities and autism spectrum disorder, which not only impact individuals and families but also have broader effects on the socioeconomic system. Despite the necessity of early detection and intensive treatment for developmental disorders, limited coverage by the national health insurance system in South Korea imposes a significant financial burden on families.
methodsIn this study, a structured survey was conducted on 105 caregivers of infants and children younger than six with developmental disorders, 52 medical doctors (child and adolescent psychiatrists, pediatricians, and rehabilitation physicians), and 51 treatment specialists to assess the economic circumstances related to developmental disorder treatment.
resultsAmong 105 children (68.6% male), most initiated treatment between ages 2 and 4, with speech therapy (88.4%) and sensory therapy (64.0%) being the most utilized services. Although Applied Behavior Analysis had the highest session intensity and cost, its voucher utilization was remarkably low (2.4%), contributing to a significant perceived financial burden, with 72.4% of caregivers reporting high burden (mean score 3.99/5). Consequently, specialists reported a discrepancy between recommended and accessible treatments due to costs, rating the reasonableness of current voucher fees at only 1.98 out of 5.
conclusionGiven the substantial financial burden, the introduction of new policies and revisions to existing policies are urgently needed to support the treatment costs for individuals with developmental disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.